Prototype project: COVID19: 20-10-covid-19-netccn-tatrc

Ended Awarded Last action

Contract number
W81XWH2090012
Awardee
Awarding agency
Obligated
$47,183,088

Award facts

Contract value 100% obligated
$47,183,088.34 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Medical Command Department of the Army, Department of Defense
NAICS code
Not on record
Set-aside
No set-aside
Competition
Competed Program Solicitation
Pricing
Other
Place of performance
Summerville, SC 29486, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00022 $0
Supplemental Agreement for work within scope P00021 $1,458,549
Supplemental Agreement for work within scope P00020 $0
Supplemental Agreement for work within scope P00019 $0
Supplemental Agreement for work within scope P00018 · 20-10-COVID19-netccn-tatrc $223,037
Supplemental Agreement for work within scope P00017 · Increase in scope 20-10-COVID19-netccn-tatrc-058 $593,632
Supplemental Agreement for work within scope P00016 · Increase in scope 20-10-COVID19-netccn-tatrc-026 $233,531
Supplemental Agreement for work within scope P00015 · Increase in scope 20-10-COVID19-netccn-tatrc-018 $396,240
Change Order P00013 · MOD to incorporate revised pals $0
Change Order P00014 · Increase in scope 20-10-COVID19-netccn-tatrc-018 $156,304
Change Order P00011 · Modification to obligate incremental funding and reallocate funds. $2,255,526
Change Order P00012 · Concept of operations MOD $0
Supplemental Agreement for work within scope P00010 · Modification to obligate phase III extension costs, cpam costs, and phase 2 follow-on costs $31,269,145
Supplemental Agreement for work within scope P00009 $948,011
Supplemental Agreement for work within scope P00008 · Modification to obligate phase III extension costs $307,496
Supplemental Agreement for work within scope P00007 · Phase III extension costs. Values do not match the increases on the modification due to a limitation that does not allow funded amount to exceed ceiling… $413,668
Supplemental Agreement for work within scope P00006 · Modification to obligate phase III extension costs $760,947
Supplemental Agreement for work within scope P00005 · Modification to extend the period of performance. $0
Supplemental Agreement for work within scope P00004 · Authorize task 3 effort and option 1 $1,228,561
Supplemental Agreement for work within scope P00003 · Advance proposal project: 20-10-covid-19-netccn-tatrc-018 to phase III $0
Supplemental Agreement for work within scope P00002 · Add phase i prototype project: COVID19: 20-10-covid-19-netccn-tatrc-021 $0
Supplemental Agreement for work within scope P00001 · Down-select for task 2, prototype project: COVID19: 20-10-covid-19-netccn-tatrc $0
Original award $6,938,442
Show all 23

About this award

Written by GovTribe AI ·

The U.S. Army Medical Command awarded a $47.2 million Other Transaction Order to Medical Technology Enterprise Consortium (MTEC) on June 9, 2020, for prototype development under the COVID-19 NETCCN-TATRC project, with completion targeted for March 29, 2024. This award was issued without set-aside designation to MTEC, a nonprofit medical technology accelerator registered in the System for Award Management since December 2015. The work will be performed in Summerville, South Carolina, and leverages MTEC's established collaborative platform that brings together industry, academic, and government partners to rapidly prototype and field innovative medical solutions for military healthcare applications.

MTEC's portfolio demonstrates extensive experience in medical research and development across multiple domains critical to military readiness, including infectious disease diagnostics, medical training systems, and operational medicine. The consortium's structure as an Other Transaction vehicle enables efficient execution of prototype projects by mobilizing its network of universities, companies, nonprofits, and research organizations. This COVID-19 focused effort aligns with the Department of Defense's broader medical modernization priorities and MTEC's established track record of translating cutting-edge medical technologies into practical solutions that enhance medical care and treatment capabilities for military personnel.

Quick answers

Who was awarded contract W81XWH2090012?

W81XWH2090012 was awarded to Medical Technology Enterprise Consortium by Defense Health Agency (Department of Defense) on June 9, 2020.

How much is contract W81XWH2090012 worth?

The government has obligated $47,183,088 on W81XWH2090012.

Which agency awarded contract W81XWH2090012?

Defense Health Agency (Department of Defense) awarded W81XWH2090012, with funding from Medical Command (Department of the Army).

Is contract W81XWH2090012 an order under another contract?

Yes. W81XWH2090012 is an other transaction order under W81XWH1590001, an other transaction IDV.

Was contract W81XWH2090012 competed?

The extent of competition for W81XWH2090012 was competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login